Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

231 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
MSH2-deficient prostate tumours have a distinct immune response and clinical outcome compared to MSH2-deficient colorectal or endometrial cancer.
McCoy P, Mangiola S, Macintyre G, Hutchinson R, Tran B, Pope B, Georgeson P, Hong MKH, Kurganovs N, Lunke S, Clarkson MJ, Cmero M, Kerger M, Stuchbery R, Chow K, Haviv I, Ryan A, Costello AJ, Corcoran NM, Hovens CM. McCoy P, et al. Among authors: costello aj. Prostate Cancer Prostatic Dis. 2021 Jun 9. doi: 10.1038/s41391-021-00379-4. Online ahead of print. Prostate Cancer Prostatic Dis. 2021. PMID: 34108644
Ductal variant prostate carcinoma is associated with a significantly shorter metastasis-free survival.
Chow K, Bedő J, Ryan A, Agarwal D, Bolton D, Chan Y, Dundee P, Frydenberg M, Furrer MA, Goad J, Gyomber D, Hanegbi U, Harewood L, King D, Lamb AD, Lawrentschuk N, Liodakis P, Moon D, Murphy DG, Peters JS, Ruljancich P, Verrill CL, Webb D, Wong LM, Zargar H, Costello AJ, Papenfuss AT, Hovens CM, Corcoran NM. Chow K, et al. Among authors: costello aj. Eur J Cancer. 2021 May;148:440-450. doi: 10.1016/j.ejca.2020.12.030. Epub 2021 Mar 5. Eur J Cancer. 2021. PMID: 33678516
Detection of ctDNA in plasma of patients with clinically localised prostate cancer is associated with rapid disease progression.
Lau E, McCoy P, Reeves F, Chow K, Clarkson M, Kwan EM, Packwood K, Northen H, He M, Kingsbury Z, Mangiola S, Kerger M, Furrer MA, Crowe H, Costello AJ, McBride DJ, Ross MT, Pope B, Hovens CM, Corcoran NM. Lau E, et al. Among authors: costello aj. Genome Med. 2020 Aug 17;12(1):72. doi: 10.1186/s13073-020-00770-1. Genome Med. 2020. PMID: 32807235 Free PMC article.
Use of prostate-specific membrane antigen positron-emission tomography/CT in response assessment following upfront chemohormonal therapy in metastatic prostate cancer.
Anton A, Kamel Hasan O, Ballok Z, Bowden P, Costello AJ, Harewood L, Corcoran NM, Dundee P, Peters JS, Lawrentschuk N, Troy A, Webb D, Chan Y, See A, Siva S, Murphy D, Hofman MS, Tran B. Anton A, et al. Among authors: costello aj. BJU Int. 2020 Oct;126(4):433-435. doi: 10.1111/bju.15151. Epub 2020 Aug 4. BJU Int. 2020. PMID: 32579772 No abstract available.
Fractionated stereotactic body radiotherapy for up to five prostate cancer oligometastases: Interim outcomes of a prospective clinical trial.
Bowden P, See AW, Frydenberg M, Haxhimolla H, Costello AJ, Moon D, Ruljancich P, Grummet J, Crosthwaite A, Pranavan G, Peters JS, So K, Gwini SM, McKenzie DP, Nolan S, Smyth LML, Everitt C. Bowden P, et al. Among authors: costello aj. Int J Cancer. 2020 Jan 1;146(1):161-168. doi: 10.1002/ijc.32509. Epub 2019 Jun 28. Int J Cancer. 2020. PMID: 31199504 Free article. Clinical Trial.
231 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page